Mersana Therapeutics (MRSN) Soars on Up to $285 Million Day One Biopharmaceuticals Buyout: All the Key News on November 13, 2025

Mersana Therapeutics is back in the headlines in a big way today after announcing a definitive agreement to be acquired by Day One Biopharmaceuticals in a deal worth up to approximately $285 million. The news has sent MRSN shares rocketing higher and triggered immediate legal and regulatory attention, making this one of the most closely watched biotech deals of the day. GlobeNewswire

13 November 2025

TechStock² Updates

Medtronic Shares Climb 3.2% Following Upgraded Outlook and $700 Million Investment in Robotics

Ambev ADR Rises 0.7% as Brazilian Beer Sales Support Margin Outlook

Nasdaq Futures Drop 1.35% as Crude Surpasses $92 and Bond Yields Climb

GoPro Surges 64% Premarket After $87 Million Debt Faces Markiplier-Led Rally

American Airlines Shares Dip 1.2% With $92 Oil Squeezing Earnings Margins

Nasdaq Futures Fall 1.2% as 10-Year Treasury Yield Approaches 4.8%

Netflix’s The Secret Woman Hits No. 2 as $25 Billion Content Commitments Face a Returns Test

Energy Soars 3.3% With Oil Approaching $92; QQQ Declines

NIO Stock Drops 1.2% as Revenue Guide Slows to 4.8% Growth

SCHD up 24%, yield trails Treasuries by 1.6 points

Investment Disclaimer